Search - tctmd.com

Displaying 301 - 320 of 1498

Sort: Relevancy | Date

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Presenter: Rebecca Smoller

March 05, 2024

Presentation THT Abstracts 2024

Newly Developed Cardiogenic Shock Team: 10 month update

Presenter: Robin Miller

March 05, 2024

Presentation THT Abstracts 2024

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Presenter: Chirag Mehta

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Presenter: Justin Cortez

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Presentation THT 2024

Deep Phenotyping in Cardiogenic Shock

Presenter: Song Li

March 05, 2024

Presentation THT 2024

Risk Stratification: Thinking Beyond SCAI Staging

Presenter: David A. Baran

March 05, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Presentation THT 2024

Innovations in Management of ECMO-Supported Patients

Presenter: E Wilson Grandin

March 05, 2024

Presentation THT 2024

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Presenter: Debapria Das

March 05, 2024

Presentation THT 2024

Innovations for RV Support in Shock

Presenter: Jaime Hernandez Montfort

March 05, 2024

Presentation THT 2024

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Presenter: José Alfredo Salinas-Casanova

March 05, 2024

Presentation THT 2024

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Presenter: Ehud Schwammenthal

March 05, 2024

Advertisement

DoReMe: Are Inotropes Helpful or Harmful?

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Newly Developed Cardiogenic Shock Team: 10 month update

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Deep Phenotyping in Cardiogenic Shock

Risk Stratification: Thinking Beyond SCAI Staging

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Innovations in Management of ECMO-Supported Patients

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Innovations for RV Support in Shock

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content